A Stock Analysis: Buy, Sell, or Hold?
A - Agilent Technologies Inc.
$138.37
-0.34 (-0.25%)
▼
5d:
-0.14%
30d:
+3.73%
90d:
+19.75%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 26, 2026
23d
Smart Money Accumulation
None View Scanner →
Strength: 6.2/10
Get Alerted When A Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: A shows positive signals but monitor for confirmation. Market pricing in 2.1% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: A shows positive signals but monitor for confirmation. Market pricing in 2.1% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$178.75
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$110.99
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: A is currently trading at $138.37, which is considered extended relative to its 30-day fair value range of $130.31 to $137.75. The stock's valuation (Forward PE: 20.9) is in line with its historical norms (19.7). At these levels, the market is pricing in 2.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, A is in a strong uptrend. The price is approaching resistance at $142.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: A has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $159.32 (+15.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, A is in a strong uptrend. The price is approaching resistance at $142.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: A has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $159.32 (+15.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$130.31 -
$137.75
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($159.32)
- NEUTRAL: Market pricing in 2.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$130.31 -
$137.75
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$125.00
Resistance Level
$142.42
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.93
Wall Street Target
$159.32
(+15.1%)
Revenue Growth (YoY)
10.0%
Earnings Growth (YoY)
60.0%
Profit Margin
19.6%
Valuation Premium vs History
+2.1% premium
PE vs Historical
20.9 vs 19.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.1%
(market-implied from PE analysis)
1-Year Target
$141.28
(+2%)
2-Year Target
$144.24
(+4%)
3-Year Target
$147.27
(+6%)
3-Yr Target (if PE normalizes)
(PE: 21→20)
PE COMPRESSION
$138.63
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.9, Growth: 9.1%)
$179.89
(+30%)
Base:
(SPY PE: 20.7, Growth: 9.1%)
$178.19
(+29%)
Bear:
(PE: 17.6, Growth: 9.1%)
$151.46
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Trailing PE: 28.19 | Current EPS (TTM): $4.92
Bull Case
$205.05
(+48%)
Analyst growth 34.4%, PE expands to 31.0
Base Case
$186.41
(+35%)
Market implied 34.4%, PE stable at 28.2
Bear Case
$94.32
(-32%)
Severe decline -20.0%, PE contracts to 24.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 6:56 PM ET
Data refreshes hourly during market hours. Next update: 7:56 PM
Data refreshes hourly during market hours. Next update: 7:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is A showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Ro Khanna
BUY
2026-03-10
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
Advanced A Option Strategies
Professional options setups generated by AI based on today's A price and gamma walls.
